Search Results - "Alon, Ury"

Ultrasensitive detection and monitoring of central nervous system tumors from plasma using personalized whole-genome ctDNA profiling by Tran, Ivy, Galbraith, Kristyn, Gardner, Sharon L., Allen, Jeffrey C., Harter, David, Wisoff, Jeffrey, Hidalgo, Eveline Teresa, Afterman, Danielle, Gonzalez, Santiago, Smadbeck, James, Lauterman, Tomer, Alon, Ury, Kandasamy, Ravi, Tavassoly, Iman, Polak, Paz, Oklander, Boris, Raju, Praveen, Zviran, Asaf, Snuderl, Matija

“…2064 Background: Patients with the central nervous system (CNS) tumors are largely followed up by imaging. Current plasma-based liquid biopsy techniques have…”
Get full text

Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma by Nordentoft, Iver, Lindskrog, Sia Viborg, Birkenkamp-Demtröder, Karin, Gonzalez, Santiago, Kuzman, Maja, Levatic, Jurica, Glavas, Dunja, Ptashkin, Ryan, Smadbeck, James, Afterman, Danielle, Lauterman, Tomer, Cohen, Yarin, Donenhirsh, Zohar, Tavassoly, Iman, Alon, Ury, Frydendahl, Amanda, Rasmussen, Mads Heilskov, Andersen, Claus Lindbjerg, Lamy, Philippe, Knudsen, Michael, Polak, Paz, Zviran, Asaf, Oklander, Boris, Agerbæk, Mads, Jensen, Jørgen Bjerggaard, Dyrskjøt, Lars

“…Detection of circulating tumor DNA (ctDNA) via whole-genome sequencing (WGS) in patients with muscle-invasive bladder cancer has great clinical potential for…”
Get full text

Accuracy of genome-wide mutational analysis for tumor-informed ctDNA-guided MRD monitoring in bladder cancer by Nordentoft, Iver, Viborg Lindskrog, Sia, Birkenkamp-Demtröder, Karin, Gonzalez, Santiago, Kuzman, Maja, Glavas, Dunja, Ptashkin, Ryan N., Smadbeck, James, Afterman, Danielle, Lauterman, Tomer, Cohen, Yarin, Donenhirsh, Zohar, Tavassoly, Iman, Alon, Ury, Polak, Paz, Oklander, Boris, Agerbaek, Mads, Jensen, Jørgen Bjerggaard, Zviran, Asaf, Dyrskjøt, Lars

“…4589 Background: Neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is the standard management of localized muscle-invasive bladder cancer…”
Get full text

Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients by Frydendahl, Amanda, Nors, Jesper, Rasmussen, Mads H., Henriksen, Tenna V., Nesic, Marijana, Reinert, Thomas, Afterman, Danielle, Lauterman, Tomer, Kuzman, Maja, Gonzalez, Santiago, Glavas, Dunja, Smadback, James, Maloney, Dillon, Levatic, Jurica, Yahalom, Michael, Ptashkin, Ryan, Tavassoly, Iman, Donenhirsh, Zohar, White, Eric, Kandasamy, Ravi, Alon, Ury, Nordentoft, Iver, Lindskrog, Sia V., Dyrskjøt, Lars, Jaensch, Claudia, Løve, Uffe S., Andersen, Per V., Thorlacius-Ussing, Ole, Iversen, Lene H., Gotschalck, Kåre A., Zviran, Asaf, Oklander, Boris, Andersen, Claus L.

“…Circulating tumor (ctDNA) can be used to detect residual disease after cancer treatment. Detecting low-level ctDNA is challenging, due to the limited number of…”
Get full text

Abstract 6689: Whole genome cell-free tumor DNA mutational signatures from blood for early detection of recurrence of low stage lung adenocarcinoma by Tran, Ivy, Vargas, Alejandro, Wilkins, Reid, Pizzillo, Isabella, Tokoro, Kenneth, Afterman, Danielle, Lauterman, Tomer, Kuzman, Maja, Gonzalez, Santiago, Glavas, Dunja, Smadbeck, James, Maloney, Dillon, Levatic, Jurica, Phillips, Samuel, Deochand, Sunil, Yahalom, Michael, Ptashkin, Ryan, Tavassoly, Iman, Donenhirsh, Zohar, White, Eric, Kandasamy, Ravi, Alon, Ury, Polak, Paz, Oklander, Boris, Zviran, Asaf, Snuderl, Matija, Pass, Harvey I.

“…Abstract Introduction: Lung cancer remains the leading cause of cancer-related deaths. Surgery is the best option for early lung cancer, and the role of…”
Get full text

Abstract 2305: Ultra-sensitive detection of circulating tumor DNA by whole-genome sequencing of blood samples from locally advanced rectal cancer patients receiving neoadjuvant therapy and enrolled in watch-and-wait strategies for organ preservation by Sanchez-Vega, Francisco, Chen, Chin-Tung, Afterman, Danielle, Omer, Dana, Darmofal, Madison, de Bruijn, Ino, Chatila, Walid K., Drescher, Matthew, Tam, Grittney, Lauterman, Tomer, Kuzman, Maja, Gonzalez, Santiago, Glavas, Dunja, Samdbeck, James, Maloney, Dillon, Levatic, Jurica, Deochand, Sunil, Yahalom, Michael, Ptashkin, Ryan, Tavassoly, Iman, Donenhirsh, Zohar, White, Eric, Kandasamy, Ravi, Alon, Ury, Berger, Michael F., Loomis, Brian, Polak, Paz, Oklander, Boris, Zviran, Asaf, Garcia-Aguilar, Julio

“…Abstract Background. We hypothesized that circulating tumor DNA (ctDNA) can be used as a prognostic biomarker, improve the assessment of response and enhance…”
Get full text

Abstract 1036: Detection of circulating tumor DNA by whole genome sequencing enables prediction of recurrence in stage III colorectal cancer patients with great inter-lab reproducibility by Frydendahl, Amanda, Nors, Jesper, Heilskov, Mads, Sørensen, Ester Ellegaard, Reinert, Thomas, Bramsen, Jesper, Afterman, Danielle, Lauterman, Tomer, Kuzman, Maja, Gonzalez, Santiago, Glavas, Dunja, Samdbeck, James, Maloney, Dillon, Levatic, Jurica, Deochand, Sunil, Yahalom, Michael, Ptashkin, Ryan, Tavassoly, Iman, Donenhirsh, Zohar, White, Eric, Kandasamy, Ravi, Alon, Ury, Polak, Paz, Madsen, Anders Husted, Løve, Uffe Schou, Andersen, Per Vadgaard, Thorlacius-Ussing, Ole, Iversen, Lene Hjerrild, Gotschalck, Kåre Andersson, Oklander, Boris, Zviran, Asaf, Andersen, Claus Lindbjerg

“…Abstract Background: Detection of circulating tumor DNA (ctDNA) in plasma indicates the presence of cancer. In patients with very few copies of tumor DNA…”
Get full text